Clinical significance of surgical treatment for imatinib-resistant gastrointestinal stromal tumors.

被引:0
|
作者
Hashimoto, Tadayoshi [1 ]
Takahashi, Tsuyoshi [1 ]
Kurokawa, Yukinori [1 ]
Kato, Ryo [1 ]
Wada, Noriko [1 ]
Tanaka, Koji [1 ]
Miyazaki, Yasuhiro [1 ]
Makino, Tomoki [1 ]
Yamasaki, Makoto [1 ]
Nakajima, Kiyokazu [1 ]
Mori, Masaki [1 ]
Doki, Yuichiro [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Osaka, Japan
关键词
D O I
10.1200/JCO.2018.36.4_suppl.189
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
189
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors
    Kikuchi, Hirotoshi
    Setoguchi, Tomohiko
    Miyazaki, Shinichiro
    Yamamoto, Masayoshi
    Ohta, Manabu
    Kamiya, Kinji
    Sakaguchi, Takanori
    Konno, Hiroyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (06) : 741 - 745
  • [22] Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
    Andtbacka, RH
    Cormier, JN
    Scaife, CL
    Hunt, KK
    Pisters, PW
    Pollock, RE
    Benjamin, RS
    Burgess, MA
    Chen, LL
    Feig, BW
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S35 - S35
  • [23] Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors
    Jason K. Sicklick
    Nicole E. Lopez
    Journal of Gastrointestinal Surgery, 2013, 17 : 1997 - 2006
  • [24] Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib
    Robert H. I. Andtbacka
    Chaan S. Ng
    Courtney L. Scaife
    Janice N. Cormier
    Kelly K. Hunt
    Peter W. T. Pisters
    Raphael E. Pollock
    Robert S. Benjamin
    Michael A. Burgess
    Lei L. Chen
    Jonathan Trent
    Shreyaskumar R. Patel
    Kevin Raymond
    Barry W. Feig
    Annals of Surgical Oncology, 2007, 14 : 14 - 24
  • [25] Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors
    Sicklick, Jason K.
    Lopez, Nicole E.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (11) : 1997 - 2006
  • [26] Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
    Andtbacka, Robert H. I.
    Ng, Chaan S.
    Scaife, Courtney L.
    Cormier, Janice N.
    Hunt, Kelly K.
    Pisters, Peter W. T.
    Pollock, Raphael E.
    Benjamin, Robert S.
    Burgess, Michael A.
    Chen, Lei L.
    Trent, Jonathan
    Patel, Shreyaskumar R.
    Raymond, Kevin
    Feig, Barry W.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) : 14 - 24
  • [27] Phase IV Study of Sunitinib in Chinese Patients with Imatinib-Resistant or Imatinib-Intolerant Gastrointestinal Stromal Tumors
    Lin Shen
    Yan Sun
    Jian-Ming Xu
    Carlos Linn
    Qiao Wang
    Li-Qiang Yang
    Shu-Kui Qin
    Oncology and Therapy, 2017, 5 (2) : 171 - 180
  • [28] Impact of pharmacogenomics on imatinib toxicity in gastrointestinal stromal tumors.
    Zhuang, Wei
    Qiu, Haibo
    Wang, Xueding
    Xin, Shuang
    Huang, Min
    Zhou, Zhiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
    Huang, Wen-Kuan
    Gao, Jiwei
    Chen, Ziqing
    Shi, Hao
    Yuan, Juan
    Cui, Huanhuan L.
    Yeh, Chun-Nan
    Branstrom, Robert
    Larsson, Catharina
    Li, Shuijie
    Lui, Weng-Onn
    CELLS, 2020, 9 (06)
  • [30] Perioperative sunitinib dosing around extensive resections of imatinib-resistant metastatic gastrointestinal stromal tumors
    Raut, C. P.
    Morgan, J. A.
    Quigley, M. T.
    George, S.
    Wagner, A. J.
    Demetri, G. D.
    Bertagnolli, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)